Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 5, 2009, Pages

  Haselkorn, Tmirah ^a   Fish, James E ^a   Zeiger, Robert S ^b   Szefler, Stanley J ^c   Miller, Dave P ^d   Chipps, Bradley E ^e   Simons, F Estelle R ^f   Weiss, Scott T ^g   Wenzel, Sally E ^h   Borish, Larry ⁱ   Bleecker, Eugene R ^j  

^a GENENTECH INC   (United States)

^b KAISER PERMANENTE   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d ICON CLINICAL RESEARCH   (United States)

^e Capital Allergy and Respiratory Disease Center   (United States)

^f UNIVERSITY OF MANITOBA   (Canada)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^j WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

more..

Author keywords

Asthma; asthma control; asthma guidelines; exacerbations; health care use; impairment domain; risk; The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens study

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; COHORT ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 71749107897     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.07.035     Document Type: Article

References (52)

1. National Center for Health Statistics, Centers for Disease Control and Prevention. Asthma. Available at: http://www.cdc.gov/nchs/fastats/asthma.htm. Accessed December 16, 2008.
2. World Health Organization. Asthma. Geneva (Switzerland) (2008), World Health Organization
3. Masoli M., Fabian D., Holt S., Beasley R., and for the Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59 (2004) 469-478
4. Pearce N., Aït-Khaled N., Beasley R., Mallol J., Keil U., Mitchell E., et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 62 (2007) 758-765
5. Braman S.S. The global burden of asthma. Chest 130 suppl (2006) 4S-12S
6. Schatz M., Zeiger R.S., Mosen D., and Vollmer W.M. Asthma-specific quality of life and subsequent asthma emergency hospital care. Am J Manag Care 14 (2008) 206-211
7. Chen H., Gould M.K., Blanc P.D., Miller D.P., Kamath T.V., Lee J.H., et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 120 (2007) 396-402
8. Weiss K.B., and Sullivan S.D. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 107 (2001) 3-8
9. Zeiger R.S., Hay J.W., Contreras R., Chen W., Quinn V.P., Seal B., et al. Asthma costs and utilization in a managed care organization. J Allergy Clin Immunol 121 (2008) 885-892 e5
10. Breekveldt-Postma N.S., Erkens J.A., Aalbers R., van de Ven M.J.T., Lammers J.W.J., and Herings R.M.C. Extent of uncontrolled disease and associated medical costs in severe asthma-a PHARMO study. Curr Med Res Opin 24 (2008) 975-983
11. Accordini S., Bugiani M., Arossa W., Gerzeli S., Marinoni A., Olivieri M., et al. Poor control increases the economic cost of asthma. A multicentre population-based study. Int Arch Allergy Immunol 141 (2006) 189-198
12. Antonicelli L., Bucca C., Neri M., De Benedetto F., Sabbatani P., Bonifazi F., et al. Asthma severity and medical resource utilisation. Eur Respir J 23 (2004) 723-729
13. Sullivan S.D., Wenzel S.E., Bresnahan B.W., Zheng B., Lee J.H., Pritchard M., et al. Association of control and risk of severe asthma-related events in severe or difficult-to-treat asthma patients. Allergy 62 (2007) 655-660
14. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Full report 2007 (2007), National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda Publication no. 97-4051
15. Expert Panel Report 3 (EPR-3). guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 120 suppl (2007) S94-S138
16. Miller M.K., Lee J.H., Miller D.P., Wenzel S.E., and for the TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 101 (2007) 481-489
17. Dolan C.M., Fraher K.E., Bleecker E.R., Borish L., Chipps B., Hayden M.L., et al. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 92 (2004) 32-39
18. Chipps B.E., Szefler S.J., Simons F.E.R., Haselkorn T., Mink D.R., Deniz Y., et al. Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma. J Allergy Clin Immunol 119 (2007) 1156-1163
19. United States Department of Agriculture. 2000 Rural-urban commuting area codes. United States Department of Agriculture, Economic Research Service. Available at: http://www.ers.usda.gov/Data/RuralUrbanCommutingAreaCodes/2000/. Accessed December 16, 2008.
20. United States Department of Agriculture Rural-urban commuting area codes. United States Department of Agriculture, Economic Research Service. Available at: http://www.ers.usda.gov/data/RuralUrbanCommutingAreaCodes/. Accessed December 16, 2008
21. US Census Bureau. United States census 2000. United States Census Bureau. Available at: http://www.census.gov/main/www/cen2000.html. Accessed December 16, 2008.
22. Ferris B.G. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 118 (1978) 1-120
23. Juniper E.F., Guyatt G.H., Epstein R.S., Ferrie P.J., Jaeschke R., and Hiller T.K. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 47 (1992) 76-83
24. Juniper E.F., Guyatt G.H., Feeny D.H., Ferrie P.J., Griffith L.E., and Townsend M. Measuring quality of life in children with asthma. Qual Life Res 5 (1996) 35-46
25. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., and King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999) 902-907
26. Juniper E.F., Buist A.S., Cox F.M., Ferrie P.J., and King D.R. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 115 (1999) 1265-1270
27. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152 (1995) 1107-1136
28. Vollmer W.M., Markson L.E., O'Connor E., Sanocki L.L., Fitterman L., Berger M., et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 160 (1999) 1647-1652
29. Asthma Therapy Assessment Questionnaire (ATAQ). Whitehouse Station (NJ): Merck & Co, Inc (2008)
30. Schatz M., Stempel D., Allen-Ramey F., Gutierrez B., Sacco P., Sajjan S., et al. Asthma quality of care measures using administrative data: relationships to subsequent exacerbations in multiple databases. J Allergy Clin Immunol 121 suppl (2008) S69
31. Schatz M., Zeiger R.S., Vollmer W.M., Mosen D., Apter A.J., Stibolt T.B., et al. Development and validation of a medication intensity scale derived from computerized pharmacy data that predicts emergency hospital utilization for persistent asthma. Am J Manag Care 12 (2006) 478-484
32. Schatz M., Mosen D., Apter A.J., Zeiger R.S., Vollmer W.M., Stibolt T.B., et al. Relationship of validated psychometric tools to subsequent medical utilization for asthma. J Allergy Clin Immunol 115 (2005) 564-570
33. Schatz M., Cook E.F., Joshua A., and Petitti D. Risk factors for asthma hospitalizations in a managed care organization: development of a clinical prediction rule. Am J Manag Care 9 (2003) 538-547
34. Covar R.A., Szefler S.J., Zeiger R.S., Sorkness C.A., Moss M., Mauger D.T., et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol 122 (2008) 741-747
35. Arnold D.H., Gebretsadik T., Minton P.A., Higgins S., and Hartert T.V. Assessment of severity measures for acute asthma outcomes: a first step in developing an asthma clinical prediction rule. Am J Emerg Med 26 (2008) 473-479
36. Belessis Y., Dixon S., Thomsen A., Duffy B., Rawlinson W., Henry R., et al. Risk factors for an intensive care unit admission in children with asthma. Pediatr Pulmonol 37 (2004) 201-209
37. Castro M., Zimmermann N.A., Crocker S., Bradley J., Leven C., and Schechtman K.B. Asthma intervention program prevents readmissions in high healthcare users. Am J Respir Crit Care Med 168 (2003) 1095-1099
38. Lafata J.E., Xi H., and Divine G. Risk factors for emergency department use among children with asthma using primary care in a managed care environment. Ambul Pediatr 2 (2002) 268-275
39. Vollmer W.M., Markson L.E., O'Connor E., Frazier E.A., Berger M., and Buist A.S. Association of asthma control with health care utilization: a prospective evaluation. Am J Respir Crit Care Med 165 (2002) 195-199
40. Sharma H.P., Matsui E.C., Eggleston P.A., Hansel N.N., Curtin-Brosnan J., and Diette G.B. Does current asthma control predict future health care use among black preschool-aged inner-city children?. Pediatrics 120 (2007) e1174-e1181
41. Apter A.J. Advances in the care of adults with asthma and allergy in 2007. J Allergy Clin Immunol 121 (2008) 839-844
42. Yoo K.H., Johnson S.K., Voigt R.G., Campeau L.J., Yawn B.P., and Juhn Y.J. Characterization of asthma status by parent report and medical record review. J Allergy Clin Immunol 120 (2007) 1468-1469
43. Miller J.E., Gaboda D., Davis D., and Centers for Disease Control and Prevention/National Center for Health Statistics. Early childhood chronic illness: comparability of maternal reports and medical records. Vital Health Stat 2 131 (2001) 1-10
44. Joseph C.L., Foxman B., Leickly F.E., Peterson E., and Ownby D. Prevalence of possible undiagnosed asthma and associated morbidity among urban schoolchildren. J Pediatr 129 (1996) 735-742
45. Jessop D.J., and Stein R.E. Consistent but not the same. Effect of method on chronic condition rates. Arch Pediatr Adolesc Med 149 (1995) 1105-1110
46. Sears M.R. Epidemiology of asthma exacerbations. J Allergy Clin Immunol 122 (2008) 662-668
47. Miller M.K., Johnson C., Miller D.P., Deniz Y., Bleecker E.R., and Wenzel S.E. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 116 (2005) 990-995
48. Chen H., Johnson C.A., Haselkorn T., Lee J.H., and Israel E. Subspecialty differences in asthma characteristics and management. Mayo Clin Proc 83 (2008) 786-793
49. Bender B.G. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 109 suppl (2002) S554-S559
50. Krishnan J.A., Riekert K.A., McCoy J.V., Stewart D.Y., Schmidt S., Chanmugam A., et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 170 (2004) 1281-1285
51. Janson S.L., Earnest G., Wong K.P., and Blanc P.D. Predictors of asthma medication nonadherence. Heart Lung 37 (2008) 211-218
52. Rand C., Bilderback A., Schiller K., Edelman J.M., Hustad C.M., and Zeiger R.S. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol 119 (2007) 916-923